Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

China Pharma Holdings, Inc. (CPHI) vs Incannex Healthcare Inc. (IXHL)

China Pharma Holdings, Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $40.7M against $31.8M — 1.3× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −114.3%) and the lower return on invested capital (−2,022.1% vs −7.23%). Across the 17 metrics below, China Pharma Holdings, Inc. leads on 10 and Incannex Healthcare Inc. on 7.

Valuation

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 7.76 26.27 2.25
P/B 0.84 0.54 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 1.18 12.29
EV/Sales 8.52 (19.01) 2.56
Earnings yield (57.33%) (514.59%) (2.99%)
Free cash flow yield (1.10%) (43.26%) 0.00%

Profitability

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Gross margin 11.76% (0.10%) 53.94%
Operating margin (111.84%) 0.00% 0.00%
Net margin (114.33%) 0.00% 0.00%
Free cash flow margin (3.59%) 0.00% 0.00%
Return on equity (20.99%) (117.17%) (0.40%)
Return on assets (15.30%) (100.36%) (3.32%)
Return on invested capital (7.23%) (2,022.08%) 0.00%

Growth

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.97%) — 10.01%
EPS growth (last fiscal year) 72.59% (17.39%) —
Revenue growth, 5-year CAGR (17.53%) (29.64%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.00 0.05
Current ratio 0.26 41.56 2.31
Net debt to EBITDA (0.98) 0.64 0.85

Dividend

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Market cap 31.83m 40.66m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack